Ignite Creation Date:
2025-12-24 @ 3:19 PM
Ignite Modification Date:
2026-01-04 @ 4:55 AM
Study NCT ID:
NCT03945292
Status:
COMPLETED
Last Update Posted:
2025-11-04
First Post:
2019-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)
Sponsor:
Arrowhead Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-08
First Submit QC Date:
None
Study First Post Date:
2019-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-18
Results First Submit QC Date:
None
Results First Post Date:
2024-12-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-12-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-11-04
Last Update Post Date Type:
ESTIMATED